Dyne Therapeutics Inc — Balance Sheet (NASDAQ:DYN) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Total assets 353.33 M425.66 M306.32 M165.08 M691.23 M1.19 B Total liabilities 10.97 M57.47 M53.96 M73.79 M61.4 M214.83 M Total equity 342.37 M368.2 M252.36 M91.29 M629.84 M972.13 M Total liabilities & shareholders' equities 353.33 M425.66 M306.32 M165.08 M691.23 M1.19 B Total debt —————169.2 M Net debt —————-941.36 M

Haberler

Raymond James, Dyne Therapeutics hissesi için Güçlü Al tavsiyesini korudu

Jefferies reiterates Buy on BioMarin stock after DMD trial data

Micron and Palantir among market cap stock movers on Tuesday

Dyne Therapeutics, Inc. (DYN) Presents at TD Cowen 46th Annual Health Care Conference Prepared Remarks Transcript

Dyne Therapeutics: Strong DELIVER Data Strengthens The Bull Case (NASDAQ:DYN)

Baird, Dyne Therapeutics hissesi için tavsiyesini korudu

Baird reiterates Dyne Therapeutics stock rating on trial progress

Jones Trading, DMD ve DM1 güncellemeleri sonrası Dyne Therapeutics hissesi için Al tavsiyesini yineledi

Jones Trading reiterates Buy on Dyne Therapeutics stock after DMD, DM1 updates

Stifel, Dyne Therapeutics için hisse tavsiyesini korudu

Stifel reiterates Dyne Therapeutics stock rating on trial design

Dyne hisseleri kas distrofisi verileri sonrası güçlendi